Most patients need long-term treatment to maintain weight loss
A variety of GLP-1RAs agents are currently available, including exenatide, liraglutide, dulaglutide, albiglutide, lixisenatide, semaglutide, and the dual GLP-1/GIP receptor agonist, tirzepatide
Stratified analyses in higher-risk groupssuch as older adults, individuals with sarcopenic obesity, or those with elevated inflammatory burdenmay further determine whether adaptive thresholds differ across metabolic contexts
(2019) report that GLP-1s may be more effective in treating alcohol use disorder than OUD
B12 injections are absorbed much better by the body because they are administered intramuscularly (into the muscle), and therefore directly into the blood
The significance of the gastroprotective effect of body protection compound (BPC): Modulation by different procedures